Association between sarcopenia and the foot-ankle function in type 2 diabetic foot ulcer

Table 2 Comparison of indicators between the Sarcopenia and non-sarcopenia groups in DF patients

	DF with sarcopenia (n = 44)	DF without sarcopenia (n = 64)	Wald χ²	P value
Lumbar T-score	-0.60 ± 1.37	0.08 ± 1.86	1.107	0.293
Femoral T-score	-1.33 ± 1.27	-0.77 ± 1.27	0.001	0.977
ASMI (kg/m²)	6.40 (5.63, 6.78)	7.27 (6.56, 7.87)	61.796	< 0.001^*
Grip strength (kg)	29 (23.7,30.78)	29.25 (22.73, 32.63)	9.987	0.002^*
5X Sit-to-stand test (s)	15.28 (13.51, 17.97)	12.59 (10.67, 14.77)	5.129	0.024^*
AOFAS ankle-hindfoot score	57 (45.5, 72)	76 (60.25, 87)	2.249	0.134
TcPO2 (mmHg)	16.65 (11, 25.7)	33.25 (17.08, 44.78)	8.775	0.003^*

The generalized linear models (GLM) was used to examine the relationship between DF with or without sarcopenia and the key parameters. Age, sex, BMI, duration of diabetes, and Wagner classification were adjusted. *P < 0.05 indicates statistical significance
DF, diabetic foot; BMC, bone mineral content. ASMI, appendicular skeletal muscle mass index. 5X Sit-stand test, five-times sit-to-stand test. AOFAS, American Orthopaedic Foot and Ankle Society ankle-hindfoot score. TcPO₂, transcutaneous oxygenpressure

ISSN: 1758-5996